Remote monitoring program for postpartum hypertension in Rhode Island
Effect of a Technology-based Collaborative Model on Persistent Hypertension and Preventive Care Attendance Among Postpartum People With Hypertensive Disorders of Pregnancy
This study is testing a new remote monitoring program for postpartum hypertension to see if it helps new moms manage their blood pressure better than the usual self-check methods.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 1536 (estimated) |
| Ages | 18 Years to 60 Years |
| Sex | Female |
| Sponsor | Women and Infants Hospital of Rhode Island Academic / other |
| Locations | 5 sites (Newport, Rhode Island and 4 other locations) |
| Trial ID | NCT06842875 on ClinicalTrials.gov |
What this trial studies
This trial evaluates the effectiveness of the Rhode Island Statewide Postpartum Hypertension Remote Surveillance (RI-SPHERES) program, which utilizes a collaborative care model to manage postpartum hypertension. It compares this technologically enabled program to a standard self-measured blood pressure (SMBP) approach, focusing on persistent hypertension at six weeks postpartum and preventive care within one year of delivery. The study aims to address barriers to in-person care, particularly for racial and ethnic minority patients, by providing remote monitoring and support. A total of 1,536 postpartum patients diagnosed with hypertensive disorders will participate in this hybrid implementation effectiveness trial.
Who should consider this trial
Good fit: Ideal candidates include postpartum patients aged 18 or older who have been diagnosed with a hypertensive disorder during pregnancy or after delivery and can communicate in English, Spanish, Portuguese, or Haitian-Creole.
Not a fit: Patients who are incarcerated or unable to provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve the management of postpartum hypertension and reduce health disparities among affected populations.
How similar studies have performed: While some studies have shown promise with self-measured blood pressure programs, this approach is novel in its focus on a collaborative care model specifically targeting postpartum hypertension.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Postpartum patient aged 18 years or more at any birthing hospital in Rhode Island * Diagnosed during pregnancy or after delivery with hypertensive disorder of pregnant * English-, Spanish-, Portuguese-, or Haitian-Creole-speaking * Smartphone ownership Exclusion Criteria: * Prior enrollment in this trial * Prisoners or incarcerated people * Inability or unwillingness to provide informed consent * Inability to communicate with study team, despite an interpreter
Where this trial is running
Newport, Rhode Island and 4 other locations
- Newport Hospital — Newport, Rhode Island, United States (Not_yet_recruiting)
- Women & Infants Hospital of Rhode Island — Providence, Rhode Island, United States (Recruiting)
- South County Hospital — Wakefield, Rhode Island, United States (Not_yet_recruiting)
- Kent Hospital — Warwick, Rhode Island, United States (Recruiting)
- Landmark Hospital — Woonsocket, Rhode Island, United States (Recruiting)
Study contacts
- Study coordinator: Stephanie Nunez, Research Coordinator
- Email: snunez@wihri.org
- Phone: 401-274-1122
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.